Mar
The advent of long-acting antiretroviral therapies (LA-ARTs) has revolutionized HIV/AIDS management by addressing adherence challenges associated with daily medication regimens. LA-ARTs offer sustained drug levels, reducing dosing frequency to weekly or monthly intervals. This review explores the clinical implications and applications of LA-ARTs in HIV/AIDS care, emphasizing their impact on treatment adherence, viral suppression and quality of life. Key studies demonstrate comparable efficacy to daily regimens with potential benefits in resource-limited settings and among marginalized populations. Challenges such as safety profiles, patient acceptance and healthcare infrastructure requirements are also discussed. As LA-ARTs continue to evolve, their integration into global HIV/AIDS treatment strategies holds promise for improving long-term outcomes and reducing transmission rates.
Comparte este artículo
English 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 